2D- and 3D-quantitative structure-activity relationship studies for a series of phenazine N,N'-dioxide as antitumour

Jonathan Da Cunha1, María Laura Lavaggi, María Inés Abasolo

  • 1Grupo de Química Medicinal, Laboratorio de Química Orgánica, Facultad de Ciencias-Facultad de Química, Universidad de la República, Montevideo, Uruguay.

Insights

Hypoxia in tumors increases resistance to cancer treatments. Phenazine dioxides, a type of bioreductive agent, can be activated in hypoxic conditions. Structure-activity relationship studies reveal key molecular features for designing more potent anticancer drugs.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Computational Chemistry

Background:

  • Tumor hypoxia is linked to resistance to radiation and chemotherapy.
  • Bioreductive agents are prodrugs activated under hypoxic conditions.
  • Phenazine dioxides represent a class of bioreductive prodrugs with potential anticancer activity.

Purpose of the Study:

  • To investigate the quantitative structure-activity relationships (QSAR) of phenazine dioxides as bioreductive agents.
  • To establish models correlating molecular descriptors with the biological activity of phenazine dioxides.
  • To guide the design of novel phenazine analogues with enhanced potency.

Main Methods:

  • 2D-quantitative structure-activity relationship (QSAR) studies using electronic and lipophilic descriptors.
  • Partial least squares (PLS) regression analysis.
  • Comparative molecular field analysis (CoMFA) and comparative molecular similarity indices analysis (CoMSIA).
  • Soft independent modeling of class analogy (SIMCA) for classification of selective cytotoxicity.

Main Results:

  • Statistically significant QSAR models were developed relating molecular descriptors to survival fractions in both oxic and hypoxic conditions.
  • CoMFA and CoMSIA models showed good predictive power for survival fractions (q² up to 0.737).
  • SIMCA models achieved high classification accuracy (up to 96%) for selective cytotoxicity.
  • Electronic and lipophilic properties were identified as crucial for phenazine dioxides' activity.

Conclusions:

  • QSAR models provide insights into the molecular recognition of phenazine dioxides as bioreductive agents.
  • The findings support the use of phenazine dioxides for targeted cancer therapy in hypoxic tumors.
  • These models are valuable for the rational design of new, more effective phenazine-based anticancer drugs.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of the aromatic...
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic antagonists are called...
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists01:29

Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists

Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...